Amber Watson

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: India

Consulting Services

Legal Support Pharma-CRO-Device IT-Web-Mobile Technology Data Science-Bioinformatics Scientific Writing

Areas Of Interest

Manufacturing and Industrial Plants Halstead-Reitan Battery Clostridium bifermentans Proteins, Membrane-Associated Corneal Dystrophy, Juvenile Epithelial of Meesmann Acetals Self-Catheterizations, Urethral Indri Antigenic Specificity Sparteine Sulfate Corticotrophin (1-39) Bidi Lasers, Holmium Doped Yttrium Aluminum Garnet Neoplasm Metastasis, Unknown Primary Division Cycles, Cell Aphorisms Receptor, Lipoprotein Aneurysm, Aortic Berardinelli Seip Congenital Lipodystrophy Type 2 Electrocorticographies, Intraoperative Continuing Dental Educations Architecture Glycerol 3 Phosphate O Acyltransferase Mass Immunization NSD 1055 Vaccinium macrocarpons alpha Fucosidase Cyclic-AMP-Dependent Protein Kinase RIIbeta Subunit Biodegradable Implants Acids, Docosahexaenoic n Butyrate Inhibitors, TNF Nonprescription Drug Misuses Tears, Artificial Genome Projects, Human Contractions, Myocardial

Professional Narrative

Dr. Amber Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Mayo Clinic 2005
Medical Writer, Harvard Med 2006

Education

Master of Science in physician assistant, Baylor College 2019
Doctor of medicine, Perelman School of Medicine 1996

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02